0001209191-21-067914.txt : 20211203
0001209191-21-067914.hdr.sgml : 20211203
20211203172046
ACCESSION NUMBER: 0001209191-21-067914
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211201
FILED AS OF DATE: 20211203
DATE AS OF CHANGE: 20211203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McHugh Miles W
CENTRAL INDEX KEY: 0001366227
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 211471181
MAIL ADDRESS:
STREET 1: C/O ACCRETIVE HEALTH, INC.
STREET 2: 401 N. MICHIGAN AVE, SUITE 2700
CITY: CHICAGO
STATE: IL
ZIP: 60611
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-01
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001366227
McHugh Miles W
C/O HORIZON THERAPEUTICS PLC,
70 SAINT STEPHEN?S GREEN
DUBLIN
L2
D02 E2X4
IRELAND
0
1
0
0
Sr VP & Princ. Acctg Officer
Ordinary Shares
2021-12-01
4
M
0
79484
22.14
A
116005
D
Ordinary Shares
2021-12-01
4
S
0
79484
106.62
D
36521
D
Stock Option (Right to Buy)
22.14
2021-12-01
4
M
0
79484
0.00
D
2025-03-22
Ordinary shares
79484
0
D
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option is fully vested and exercisable.
/s/ Miles W. McHugh
2021-12-03